91AV

Introduction

Day One

Track 1: Identification & Validation of Novel Targets
Track 2: Animal Models for Disease, Organ Modelling - Organoid based Discovery & Organ On Chip development 
Track 3:  On Target, Phenotypic, Affinity and Virtual based Screening 
Track 4: Computational Drug Design

Day Two: 

Track 1: Emerging Modalities of Drug Discovery
Track 2: Functional Genomics & Genetics in Drug Discovery
Track 3: Hit Finding Technologies And Advancements
Track 4: Molecular Drug Design and Medicinal 91AV 

Deadlines

• Jun 01 2023
  Standard registration deadline

  

Useful links

Speakers

• Malcolm Weir Executive Officer, Vice President
  Sosei Heptares, Germany
• Ulrich Betz Vice President Innovation, Head of Department
  Merck, United Kingdom
• Matthias Frech Director, Molecular Interactions & Biophysics
  Merck, United Kingdom
• Clara Christ Head of Computational Molecular Design
  Bayer, Germany
• Olivier Nosjean Head of Open Innovation and Scientific Affairs, R&D
  Servier, Germany
• Nadeem Sarwar Global Head, Genomic Strategies & Global Head
  Eisai, Germany

---

Venue

Maritim proArte Hotel Berlin

Maritim proArte Hotel Berlin, Friedrichstrasse 151, Dorotheenstrasse 65, Berlin, 10117 Berlin, Germany

Useful links

Organised by

Oxford Global Conferences

Contact information

Harry Liddiard
Oxford Global Conferences
+44 1865 248455
Contact us by email

---